AUA - Audeara Limited

[System]

Audeara was incorporated on 23 February 2015, founded by Brisbane based doctors and engineers, Dr James Fielding, Dr Chris Jeffery and Alex Afflick.

Audeara is a hearing health technology company that has developed a hearing profile algorithm used to personalise sound output to the needs of the individual. The first product to be designed, commercialised and produced is the Audeara A–01 headphone with accompanying BT–01 Bluetooth transceiver.

Audeara's mobile application uses a proprietary personalisation algorithm and software interface to produce tailored audio for users of associated audio listening devices.

Audeara's technology platform allows customers to enjoy sound personalised for their unique hearing profile, offering a superior sound experience and quality, while promoting the importance of their hearing health.

Audeara's A–01 product offering is noise–cancelling consumer headphones that deliver high–quality and personalised audio to users. The headphones are designed for use in mainstream applications, such as listening to music, streaming movies, and television, video chat and PC and console gaming. Audeara's headphones may be categorised as assistive listening devices (ALDs).

It is anticipated that AUA will list on the ASX during May 2021.

Audeara

Audeara is a global hearing health leader specialised in innovative listening solutions.

audeara.com

 

[Dona Ferentes]

Listing date	14 May 2021 11:00 AM ##
Contact details	https://audeara.com/ 1300 251 539
Principal Activities	Development and commercialisation of headphones and other assistive listening devices
GICS industry group	TBA
Issue Price	$0.20
Issue Type	Ordinary Fully Paid Shares
Security code	AUA
Capital to be Raised	$7,000,000
Expected offer close date	5 May 2021
Underwriter	This offer is fully underwritten. Morgans Corporate Limited (Underwriter and Lead Manager)

 

[Dona Ferentes]

listed a few days late... the 20c IPO came on at 20.5c but now down around 17c

oh dear

 

[Miner]

Extract from Stockhead

"
Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.

Themes of the week​

Healthcare finished the week up 1.58 per cent, compared to the broader market which rose by 0.23 per cent.
Inflation anxiety in Australia and overseas continued to play out on growth stocks this week, causing volatility in the share prices of biotech stocks.
Hearing tech company Audeara (ASX:AUA) made its ASX debut on Tuesday, but the stock price has tanked and fallen to 14.5c, below its IPO price of 20c.
Morgans was the IPO manager for Audeara, and Power remains bullish on the stock and the hearing technology segment in general.
“The thesis on this stock still remains intact, as there is definitely an increasing trend towards hearing health,” he said.
Audeara makes headphones designed to complement hearing aids, helping people with entertainment experiences, such as watching TV.
“We believe there is a big upside for Audeara in terms of growing overseas in markets like the US,” he argued.
We have seen another hearing aid company with a full-page advertisement on West Australian NUH, still struggling to attract the market.
Would AUA deliver any additional benefit to become a midget Cohlear COH?
What the group's comments on understanding the two stocks AUA and NUH to be rising above the ashes sooner?
DNH